GRAND RAPIDS, Mich., Nov. 13, 2025 /PRNewswire/ -- HAPPE Spine, an early stage company advancing clinical outcomes with a proprietary biomaterial and manufacturing platform for creating ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has given 510(k) clearance to HAPPE Spine’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback